-transparent.png){kind=logo}
Membrane microparticles (MP) produced upon cell activation and/or damage possess coagulation activity, i.e. ability to accelerate blood clotting. They contain on their surface phosphatidylserine (PS), a substrate for assembling coagulation enzymatic complexes, and some of them tissue factor (TF), the initiator of clotting cascade reactions. In this study coagulation properties of MP derived from erythrocytes have been investigated. These MP were obtained from donor's erythrocytes activated with ionophore A23187 as well as from outdated erythrocyte concentrates for transfusion. MP were counted by flow cytometry. Coagulation activity of MP was examined by modified plasma recalcification assay. Involvement of PS and TF in this reaction was assessed using PS blocker lactadherin and anti-TF antibodies. TF activity in MP was measured by its ability to activate factor X in a chromogenic assay. Size of MP was evaluated by dynamic light scattering. Properties of erythrocyte MP were compared with previously characterized (using the same methodological approaches) MP derived from platelets and monocytic THP-1 cells, lacking and containing TF, respectively. Erythrocyte MP accelerated plasma clotting, but less actively than MP from platelets and MP from THP-1 cells, which demonstrated maximal activity. Lactadherin completely inhibited coagulation activity of all MP. Anti-TF antibodies did not affect clotting parameters in the presence of platelet and erythrocyte MP, but slowed clotting in the presence of MP from THP-1 cells. TF activity was not detected in erythrocyte and platelet MP, unlike MP from THP-1 cells expressing active TF. MP derived from erythrocytes were smaller than MP from platelets and THP-1 cells, with average diameter about 200 nm and 400 nm respectively. Thus, MP from erythrocyte possess less ability to accelerate plasma clotting in comparison with MP from platelet and THP-1 cells. The data obtained suggest that lesser coagulation activity of erythrocyte MP in comparison with MP from THP-1 cells is due to the absence of TF in erythrocyte MP (in contrast to MP from THP-1 cells) and to their smaller size, and in comparison with MP from platelets (which as erythrocyte MP do not express TF) is due to their smaller size only.
O A Antonova, and
O N Shustova, and
N V Golubeva, and
V V Yakushkin, and
I B Alchinova, and
M Y Karganov, and
A V Mazurov
January 2014,
PloS one,
O A Antonova, and
O N Shustova, and
N V Golubeva, and
V V Yakushkin, and
I B Alchinova, and
M Y Karganov, and
A V Mazurov
November 2009,
Haematologica,
O A Antonova, and
O N Shustova, and
N V Golubeva, and
V V Yakushkin, and
I B Alchinova, and
M Y Karganov, and
A V Mazurov
December 1957,
Thrombosis et diathesis haemorrhagica,
O A Antonova, and
O N Shustova, and
N V Golubeva, and
V V Yakushkin, and
I B Alchinova, and
M Y Karganov, and
A V Mazurov
July 2011,
Medicine and science in sports and exercise,
O A Antonova, and
O N Shustova, and
N V Golubeva, and
V V Yakushkin, and
I B Alchinova, and
M Y Karganov, and
A V Mazurov
December 1984,
Biochemistry,
O A Antonova, and
O N Shustova, and
N V Golubeva, and
V V Yakushkin, and
I B Alchinova, and
M Y Karganov, and
A V Mazurov
January 2020,
Advances in hematology,
O A Antonova, and
O N Shustova, and
N V Golubeva, and
V V Yakushkin, and
I B Alchinova, and
M Y Karganov, and
A V Mazurov
January 2009,
Pharmacological reports : PR,
O A Antonova, and
O N Shustova, and
N V Golubeva, and
V V Yakushkin, and
I B Alchinova, and
M Y Karganov, and
A V Mazurov
December 2012,
Journal of proteomics,
O A Antonova, and
O N Shustova, and
N V Golubeva, and
V V Yakushkin, and
I B Alchinova, and
M Y Karganov, and
A V Mazurov
October 2008,
Thrombosis and haemostasis,
O A Antonova, and
O N Shustova, and
N V Golubeva, and
V V Yakushkin, and
I B Alchinova, and
M Y Karganov, and
A V Mazurov
January 1969,
Minerva pediatrica,
